scispace - formally typeset
J

Josep Costa

Researcher at University of Girona

Publications -  248
Citations -  10814

Josep Costa is an academic researcher from University of Girona. The author has contributed to research in topics: Delamination & Hepatitis C virus. The author has an hindex of 43, co-authored 235 publications receiving 9667 citations. Previous affiliations of Josep Costa include Carlos III Health Institute & Benemérita Universidad Autónoma de Puebla.

Papers
More filters
Journal ArticleDOI

Effect of ply-thickness on the impact response of interleaved thin-ply non-crimp-fabric laminates: X-ray tomography investigation

TL;DR: Sihn et al. as mentioned in this paper devised an impact, compression after impact (CAI) and quasi-static indentation (QSI) experimental campaign, where computerized X-ray tomography provided detailed 3D insight on how matrix cracking, delamination and fibre failure interacted during impact and QSI.
Journal ArticleDOI

Composition Analysis of RF Plasma-Deposited Amorphous Silicon Oxynitride Thin Films by Spectroscopic Phase-Modulated Ellipsometry

TL;DR: In this paper, the Bruggeman effective medium theory was applied on thin films of highly transparent amorphous silicon oxynitride (a-SiOxNy:H) in a PECVD reactor provided with an in situ phase-modulated ellipsometer.

Simulation of Delamination Under High Cycle Fatigue in Composite Materials Using Cohesive Models

TL;DR: In this article, a new thermodynamically consistent damage model is proposed for the simulation of high-cycle fatigue crack growth, based on an interfacial degradation law that links Fracture Mechanics and Damage Mechanics to relate the evolution of the damage variable, d, with the crack growth rate.
Journal ArticleDOI

Classification of measles breakthrough cases in an elimination setting using a comprehensive algorithm of laboratory results: why sensitive and specific IgM assays are important.

TL;DR: In this paper, the authors classified 19 confirmed measles breakthrough cases (BC) using a high-performance avidity assay developed in 2010, using clinical and epidemiological data collected during a 2006 measles outbreak in Spain.